Evidence map›Paper›PMID 26139536›Full record

ArticleThe EMBO journal2015

mTOR activates the VPS34-UVRAG complex to regulate autolysosomal tubulation and cell survival.

Michael J Munson, George Fg Allen, Rachel Toth, David G Campbell, John M Lucocq, Ian G Ganley

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Michael J MunsonMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK.
George Fg AllenMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK.
Rachel TothMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK.
David G CampbellMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK.
John M LucocqSchool of Medicine University of St Andrews, St Andrews, UK.
Ian G GanleyMRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences University of Dundee, Dundee, UK i.ganley@dundee.ac.uk.
MRC Protein Phosphorylation and Ubiquitylation Unit · GBUniversity of Dundee · GBUniversity of St Andrews · GB

Funding

Medical Research Council MC_UP_A500_1019Medical Research Council MC_UU_12016/4Medical Research Council MR/K015869/1Wellcome Trust 097945Wellcome Trust 097945/B/11/Z
6 · The paper itself

Abstract

Lysosomes are essential organelles that function to degrade and recycle unwanted, damaged and toxic biological components. Lysosomes also act as signalling platforms in activating the nutrient-sensing kinase mTOR. mTOR regulates cellular growth, but it also helps to maintain lysosome identity by initiating lysosomal tubulation through a process termed autophagosome-lysosome reformation (ALR). Here we identify a lysosomal pool of phosphatidylinositol 3-phosphate that, when depleted by specific inhibition of the class III phosphoinositide 3-kinase VPS34, results in prolonged lysosomal tubulation. This tubulation requires mTOR activity, and we identified two direct mTOR phosphorylation sites on UVRAG (S550 and S571) that activate VPS34. Loss of these phosphorylation sites reduced VPS34 lipid kinase activity and resulted in an increase in number and length of lysosomal tubules. In cells in which phosphorylation at these UVRAG sites is disrupted, the result of impaired lysosomal tubulation alongside ALR activation is massive cell death. Our data imply that ALR is critical for cell survival under nutrient stress and that VPS34 is an essential regulatory element in this process.

Indexed as

AnimalsClass III Phosphatidylinositol 3-KinasesHEK293 CellsHeLa CellsHumansLysosomesMiceMultiprotein ComplexesPhosphorylationTOR Serine-Threonine KinasesTumor Suppressor ProteinsClass III Phosphatidylinositol 3-KinasesMTOR protein, humanmTOR protein, mouseMultiprotein ComplexesTOR Serine-Threonine KinasesTumor Suppressor ProteinsUVRAG protein, humanUVRAG protein, mouselysosomemTORtubuleUVRAGVPS34

Identifiers

PMID26139536
PMCPMC4585463
OpenAlexW2135453787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.